Quoin Pharmaceuticals, Ltd. - 10-Q Filing
Quoin Pharmaceuticals filed its 10-Q for the quarter ended March 31, 2026, reporting ongoing operations as a biopharmaceutical company focused on developing treatments for rare diseases. The filing includes financial statements and disclosures related to research and development expenses, general and administrative expenses, and capital structure, including common stock and additional paid-in capital balances. The company also disclosed a private placement in January 2026 and ongoing licensing agreements.
Tickers: $QNRX